{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:43Z","timestamp":1707524383794},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,12]]},"DOI":"10.7759\/cureus.20356","type":"journal-article","created":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T13:15:25Z","timestamp":1639314925000},"source":"Crossref","is-referenced-by-count":2,"title":["Hyperhemolysis in the Setting of Mixed-Autoimmune Hemolytic Anemia: A Rare Complication of COVID-19"],"prefix":"10.7759","author":[{"given":"Sonya","family":"Narula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Winkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Truitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004879","article-title":"Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry","volume":"49","author":"Domecq JP","year":"2021","unstructured":"Domecq JP, Lal A, Sheldrick CR, et al.. Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry. Crit Care Med. 2021, 49:437-48. 10.1097\/CCM.0000000000004879","journal-title":"Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16794","article-title":"Autoimmune haemolytic anaemia associated with COVID-19 infection","volume":"190","author":"Lazarian G","year":"2020","unstructured":"Lazarian G, Quinquenel A, Bellal M, et al.. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol. 2020, 190:29-31. 10.1111\/bjh.16794","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14740\/jh906","article-title":"Hemolytic anemia complicating COVID-19 infection","volume":"10","author":"AbouYabis AN","year":"2021","unstructured":"AbouYabis AN, Bell GT. Hemolytic anemia complicating COVID-19 infection. J Hematol. 2021, 10:221-7. 10.14740\/jh906","journal-title":"J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2015.03.005","article-title":"Hyperhemolysis syndrome in a patient with sickle cell anemia: case report","volume":"37","author":"Gouveia ME","year":"2015","unstructured":"Gouveia ME, Soares NB, Santoro MS, de Azevedo FC. Hyperhemolysis syndrome in a patient with sickle cell anemia: case report. Rev Bras Hematol Hemoter. 2015, 37:266-8. 10.1016\/j.bjhh.2015.03.005","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16883","article-title":"Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?","volume":"190","author":"Angileri F","year":"2020","unstructured":"Angileri F, L\u00e9gar\u00e9 S, Marino Gammazza A, Conway de Macario E, Macario AJ, Cappello F. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?. Br J Haematol. 2020, 190:e92-3. 10.1111\/bjh.16883","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006695","article-title":"Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19","volume":"136","author":"Berzuini A","year":"2020","unstructured":"Berzuini A, Bianco C, Paccapelo C, et al.. Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19. Blood. 2020, 136:766-8. 10.1182\/blood.2020006695","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99291-z","article-title":"Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study","volume":"11","author":"Dur\u00e1n-M\u00e9ndez A","year":"2021","unstructured":"Dur\u00e1n-M\u00e9ndez A, Aguilar-Arroyo AD, Vivanco-G\u00f3mez E, et al.. Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study. Sci Rep. 2021, 11:19728. 10.1038\/s41598-021-99291-z","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16103","article-title":"Treatment of post-transfusion hyperhaemolysis syndrome in sickle cell disease with the anti-IL6R humanised monoclonal antibody Tocilizumab","volume":"186","author":"Sivapalaratnam S","year":"2019","unstructured":"Sivapalaratnam S, Linpower L, Sirigireddy B, Agapidou A, Jain S, Win N, Tsitsikas DA. Treatment of post-transfusion hyperhaemolysis syndrome in sickle cell disease with the anti-IL6R humanised monoclonal antibody Tocilizumab. Br J Haematol. 2019, 186:e212-4. 10.1111\/bjh.16103","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67604-hyperhemolysis-in-the-setting-of-mixed-autoimmune-hemolytic-anemia-a-rare-complication-of-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:55Z","timestamp":1707507235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67604-hyperhemolysis-in-the-setting-of-mixed-autoimmune-hemolytic-anemia-a-rare-complication-of-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,12]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.20356","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,12]]}}}